Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation

• Egile Nagusiak: Xiangjiao Yi (Egilea), Jianguo Tao (Egilea), Yu Qian (Egilea), Feng Feng (Egilea), Xueqin Hu (Egilea), Taotao Xu (Egilea), Hongting Jin (Egilea), Hongfeng Ruan (Egilea), Hou-Feng Zheng (Egilea), Peijian Tong (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

No drug options exist for skeletal muscle atrophy in clinical, which poses a huge socio-economic burden, making development on drug interventions a general wellbeing need. Patients with a variety of pathologic conditions associated with skeletal muscle atrophy have systemically elevated inflammatory...